STUP 001
Alternative Names: LYH-001; STUP-001Latest Information Update: 27 Jan 2023
At a glance
- Originator Stand Up Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Spinal cord injuries
Most Recent Events
- 02 Jan 2023 Preclinical trials in Spinal cord injuries in South Korea (Parenteral) (Stand Up Therapeutics pipeline, January 2023)
- 30 Dec 2022 Stand Up Therapeutics and VectorBuilder agree to develop and supply STUP 001 in Spinal cord injuries
- 29 Dec 2022 Stand Up Therapeutics plans a phase I/IIa trial for Paraplegia in first quarter of 2023